Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

Introduction of wild-type (wt) p53 by means of adenoviral vectors has been shown to inhibit, both in vitro and in mouse xenograft models, the growth of various types of tumors. We have shown that ...